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Human T lymphotropic virus type 1 (HTLV-1) is considered the etiologic agent of adult T cell leukemia/lymphoma and
several chronic progressive immune-mediated diseases. Approximately 1–4% of infected individuals develop disease, gener-
ally decades following infection. Increased proviral transcription, mediated by the viral 40-kDa trans-activating protein, Tax,
has been implicated in the pathogenesis of HTLV-1-associated diseases. Since the HTLV-1 promoter contains sequences
responsive to cyclic AMP and protein kinase C, we hypothesized that lymphocyte activation signals initiated through the
TCR/CD3 complex or CD2 receptor promote viral replication in HTLV-1-infected lymphocytes. We demonstrate that mAbs
directed against the CD2, but not the CD3 receptor increase viral p24 capsid protein 1.5- to 5.7-fold in CD2/CD3/ HTLV-
1-infected cell culture supernatants. Northern blot analysis demonstrated a 2.5- to 4-fold increase in all species of viral
mRNA following CD2 cross-linking of OSP2/4 cells, an immortalized HTLV-1 cell line. Consistent with transcriptional regula-
tion, reporter gene activity increased approximately 11-fold in CD2-stimulated Jurkat T cells cotransfected with a Tax-
expressing plasmid and a CAT reporter gene construct under control of the HTLV-1 promoter. These data suggest a possible
physiologic mechanism, whereby CD2-mediated cell adhesion and lymphocyte activation may promote viral transcription
in infected lymphocytes. q 1997 Academic Press
INTRODUCTION hances phosphorylation and dissociation of I-kB, pro-
moting nuclear localization of the NF-kB family of tran-
Human T-lymphotropic virus type 1 is considered the scription factors and increasing transcription from pro-
etiologic agent of adult T cell leukemia/lymphoma moters with NF-kB responsive elements (Ballard et al.,
(ATLL) (Hinuma et al., 1981; Poeisz et al., 1980; Takat- 1988; Kanno et al., 1995). Through multiple signaling
suki et al., 1977; Yoshida et al., 1982) and is associated mechanisms Tax thus trans-activates cellular genes of
with several progressive immune-mediated diseases, proliferation and potential neoplastic transformation, in-
including HTLV-1-associated myelopathy/tropical spas- cluding c-fos and IL-2Ra (Sodroski et al., 1984; Greene
tic paraparesis (HAM/TSP) (Gessain et al., 1985; Osame et al., 1986; Inoue et al., 1986; Brady et al., 1987; Nyborg
et al., 1986), certain forms of polyarthritis (Nishioka et et al., 1988; Ruben et al., 1988; Marriott et al., 1989;
al., 1989), polymyositis (Morgan et al., 1989), and uveitis Fujisawa et al., 1991; Wagner et al., 1993).
(Mochizuki et al., 1992). Following cell-associated trans- Defining the host cell–viral interactions initiating tran-
mission, the virus establishes lifelong infection with scription from the integrated HTLV-1 provirus may there-
minimal viral expression during asymptomatic periods fore be key in understanding the pathogenesis of HTLV-
(Varmus, 1988). Approximately 4% of infected individuals 1-associated diseases. The viral regulatory protein Tax
develop HTLV-1-associated disease. While the mecha- trans-activates the HTLV-1 promoter in part, through cy-
nisms through which this occurs are unclear, initiation clic AMP (cAMP) and protein kinase C (PKC)-responsive
of neoplastic transformation requires expression of the elements within the viral promoter (Jeang et al., 1988;
viral 40-kDa trans-activating protein, Tax (Kinoshita et Poteat et al., 1989; Radonovich et al., 1989; Green et al.,
al., 1989; Kira et al., 1991). While not a DNA-binding 1990; Kadison et al., 1990; Lindholm et al., 1996; Poteat
protein itself, Tax forms ternary complexes and en- et al., 1996). Since these second messenger pathways
hances binding of the cyclic AMP response element are triggered through membrane receptors during T lym-
binding protein (Tie, 1996) and promotes dimerization phocyte differentiation and activation, we postulated that
and binding of a number of other cellular transcription activation through normal cell signaling pathways, the
factors (reviewed by Yoshida, 1995; Yoshimura et al., CD2 receptor and TCR/CD3 complex, might enhance vi-
1990; also Fujii et al., 1991; Beimling et al., 1992; Zhao ral replication in HTLV-1-infected lymphocytes.
et al., 1992; Barnhart et al., 1997). In addition, Tax en- CD2 signaling is particularly relevant to HTLV-1 infec-
tion, as HTLV-1-infected lymphocytes are mitogenic to
resting T cells and thymocytes through CD2 activation1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (614) 292-6473. E-mail: Lairmore.1@osu.edu. pathways (Gazzolo et al., 1987). Monoclonal antibodies
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against either the T11.1 or T11.2 epitopes of the CD2 Receptor cross-linking
receptor competitively block HTLV-1-mediated lympho-
Receptor cross-linking was performed as previously de-cyte proliferation (Duc Dudon et al., 1989). This CD2-
scribed (Guyot et al., 1996). Briefly, cells were harvested,mediated effect requires direct cell contact between
resuspended in complete medium at 0.5 1 106 cells/mlHTLV-1-infected and target lymphocytes and possibly
and aliquots placed in stimulation protocols. Anti-CD3HTLV-1 replication (Kimata et al., 1993; Martin et al.,
mAb was bound to wells of 6-, 24-, or 96-well plates by1996). Viral replication and production of Tax may block
incubating a 1:200 dilution of mAb in incomplete RPMI forinhibition of cdk4 kinase activity by the cyclin-dependent
1 hr at 377 (OKT3, 0.625 mg/ml final concentration, Orthokinase inhibitor p16INK4A thus enabling cell cycle progres-
Diagnostic Systems Inc. Rariton, NJ). The anti-CD2 mAbssion (Suzuki, 1996; Low, 1997). In concert, these studies
39C1.5 and 6F10.3 (T11.1 and T11.2 epitopes, respectively,suggest a mechanism for the spontaneous proliferation
Immunotech, Inc., Westbrook, ME) were used in solubleobserved in HTLV-1-infected lymphocytes in vitro and
form paired at 2.5 mg/ml in RPMI. A mouse mAb to bovinesuggest that CD2 ligation may be significant in the viral
prolactin (prl) served as a nonbinding control (2.5 mg/mllife cycle, potentially enhancing transmission of cell-as-
clone 6F11, courtesy of Dr. Charles Brooks, The Ohio Statesociated HTLV-1. Alternatively, CD2 modulation may in-
University). To verify effectiveness of the stimulation proto-crease transcription from the integrated provirus, as has
col, cell proliferation was assessed concurrently by de-been demonstrated in HIV-infected lymphocytes (Bres-
termining [3H]thymidine incorporation in both the cell linessler et al., 1991). In this study we evaluated the effects
and PBMC. Consistent with our previous results (Guyot etof CD2 and CD3 modulation on viral replication in HTLV-
al., 1996), CD2 cross-linking routinely increased [3H]-1-infected lymphocytes. The data indicate that CD2
thymidine incorporation in resting PBMC from 3- to 12-cross-linking increases expression of HTLV-1 p24 protein
fold over that observed in unstimulated cells, but inhibitedand messenger RNA in CD2/ HTLV-1-transformed cell
[3H]thymidine incorporation from 10 to 60% in the CD2/lines and increases reporter gene activity in Jurkat tran-
HTLV-1-infected cell lines. CD3 cross-linking increasedsiently cotransfected with the viral long terminal repeat
[3H]thymidine incorporation in PBMC from 15- to 35-fold(LTR) and Tax. CD3 cross-linking failed to significantly
over that observed in unstimulated cells, but did not affectincrease HTLV-1 p24 protein production in HTLV-1-in-
[3H]thymidine incorporation in any of the cell lines evalu-fected cell lines and resulted in minimally increased LTR-
ated. While Jurkat are used extensively for evaluation ofreporter gene activity in transfected Jurkat. These data
the CD2 and CD3 signaling pathways, they are a trans-suggest that CD2 cross-linking promotes HTLV-1-LTR
formed cell line and cycle continuously. Receptor stimula-transcription and suggest an important mechanism,
tion could not increase the rate at which they progresswhereby cell adhesion may promote the replication of
through the cell cycle. We therefore verified that they re-this highly cell-associated retrovirus.
sponded to CD2 and CD3 receptor stimulation by monitor-
ing elevated levels of phosphorylated CREB following re-MATERIALS AND METHODS
ceptor cross-linking, data not shown.
Cell lines and PBMC
Antigen captureJurkat and the established HTLV-1-infected lymphocyte
cell lines OSP1, OSP2/4, OSP3, C10MJ, and MT-2:4 HTLV-1-infected and uninfected cells were pelleted,
(Kaplan et al., 1991; McKendall et al., 1991; Miyoshi et al., resuspended in fresh medium at 0.5 1 106 cells/ml, and
1981; Popovic et al., 1983; Ratner et al., 1990; Rowe et triplicate 100-ml aliquots placed in stimulation protocols
al., 1995) were seeded at 0.5 1 106 cells/ml in complete using a 96-well plate format (Sumilon; Sumitoma Bakelit
RPMI 1640 supplemented with 0.3 mg/ml L-glutamine, 100 Co. Ltd., Tokyo, Japan). Supernatants were harvested and
U/ml penicillin, 100 mg/ml streptomycin, and 10% FBS. assayed for p24 capsid protein 8 to 48 hr after receptor
Cell lines were maintained at 377 in 7% CO2 and passed stimulation using a commercially available antigen cap-
three times weekly. OSP1, OSP2/4, and OSP3 are IL-2 ture assay (HTLV-1, II Ag Assay, Coulter Immunology,
dependent and were supplemented with 10 U/ml rIL-2 Hialeah, FL), capable of detecting as little as 15 pg/ml
(Boehringer-Mannheim Biochemical, Indianapolis, IN). All p24 protein. Resultant absorption values were compared
lines were previously characterized by flow cytometry for to a standard curve generated in the same trial. Data
surface expression of CD2, CD3, CD4, CD8, and CD25 are expressed as pg/ml of p24 protein released into the
receptors (Guyot et al., 1996). Jurkat, OSP1, OSP2/4, and supernatant, and are averaged from triplicate aliquots of
OSP3 express moderate to high levels of both CD2 and 0.5 1 105 cells/well as initially seeded.
CD3 receptors on their surface (29– 96% of cells positive).
C10MJ and MT-2:4 do not express significant levels of Northern blot analysis
either CD2 or CD3 and are used as controls for nonspe-
cific mAb effects. Peripheral blood mononuclear cells Northern blot analyses were performed as previously
described (Andrews et al., 1995) in a 6-well plate format.were isolated from an HTLV-1-negative donor as pre-
viously described (Newbound et al., 1996). Total RNA was harvested from 1 1 107 stimulated or
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unstimulated OSP2/4 cells using a guanidinium isothyo-
cyanate based technique (RNAzol, Tel-Test‘‘B’’ Friends-
wood, TX). RNA was resuspended in 30 ml FORMAzol
(Molecular Research Center, Inc. Cincinnati, OH), 10 mg
electrophoresed in a 1.2% agarose/formaldehyde gel,
and transferred to nylon membrane by capillary action
(S & S Nytran, Schleicher and Schuell, Keene, NH). Mem-
branes were probed with a randomly 32P-labeled HTLV-
1 LTR probe (Decaprime kit; Ambion Inc, Austin, TX),
which detects all major species of HTLV-1 RNA. Follow-
ing hybridization, membranes were stringently washed
and specific activity was determined by phospho-im-
aging analysis (Phospho-imager model 445-PC, analyzed
FIG. 1. CD2 cross-linking increased viral p24 capsid protein detected
by ImageQuaNT version 4.1b, Molecular Dynamics, Sun- in all three of the CD2/ HTLV-1-infected cell lines evaluated. Triplicate
neyvale, CA). As a loading control, membranes were samples of cells were stimulated as indicated under Materials and
Methods and culture supernatants harvested 48 hr poststimulation.stripped and reprobed with an end-labeled oligonucleo-
Results are presented from 1 of 3 representative experiments and aretide probe specific for the human 28S ribosomal subunit
expressed as pg of p24 protein per milliliter of supernatant { SD. CD2(Clontech Laboratories, Inc., Palo Alto, CA).
cross-linking increased levels of p24 protein an average of 1.6-fold
over that observed in unstimulated OSP1 cells (range 1.2- to 2.3-fold),Transfections
5.6-fold in OSP2/4 cells (range 1.5- to 7.5-fold), and 1.5-fold in OSP3Jurkat were transiently transfected by electroporation
cells (range 1.25- to 2-fold). No effect was observed in the CD2-negative
as previously described (Newbound et al., 1995) using cell lines, C10MJ or MT-2:4. Neither CD3 cross-linking nor the prl con-
either 7.5 mg of pU3R1-CAT (Sodroski et al., 1984), which trol mAb had a significant effect on p24 production in any of the cell
lines evaluated. Statistical analysis was performed by paired analysiscontains the full-length HTLV-1 promoter, or 7.5 mg of a
of variance and P values presented reflect levels of significance ob-5* LTR deletional construct, dl6-2-CAT, from which se-
tained for all three experiments. *P  0.01; †P  0.001.quences upstream of 052 have been deleted, including
the Tax-responsive elements (Brady et al., 1987). Trans-
fections were performed either with or without cotrans- mediator of activation-induced apoptosis in thymocytes
fection of 2 mg of the Tax-expressing plasmid, pCMV-tax (Mentz et al., 1995) and causes a reversible growth arrest
(courtesy of Dr. John Brady, NIH). Transfected cells were in HTLV-1-infected lymphocytes while concurrently in-
pooled and rested 1 hr. Cells were then counted, resus- creasing transcription from the HTLV-1 provirus (Poteat
pended at 0.5 1 106 viable cells/ml, and triplicate 1-ml et al., 1996). Analogously, we previously determined that
aliquots placed into receptor stimulation protocols using CD2 cross-linking induced apoptosis in CD2/ HTLV-1-
a 24-well plate format. At the indicated time points cells infected lymphocyte cell lines (Guyot et al., 1996). To
were harvested into 100 ml of cell lysis buffer and 50 ml determine whether CD2 or CD3 receptor activation con-
was assayed for CAT activity as described using the currently enhanced viral replication we screened HTLV-
differential solubility of n-butyrylated [14C]chloramphe- 1-infected cell lines for p24 capsid protein in cell culture
nicol in organic solvents and measuring counts per mi- supernatants 8 to 48 hr after CD2 or CD3 cross-linking.
nute of 14C by liquid scintillation counting (Promega, Mad- Peak levels of p24 protein were observed 48 hr after
ison, WI). Protein concentrations were determined spec- receptor stimulation (time course kinetics not shown).
trophotometrically to ensure that similar amounts of pro- CD2 cross-linking significantly increased p24 protein de-
tein were evaluated, and results were corrected to the tected in the CD2/ HTLV-1-infected cell lines from 1.5-
control. Transfection efficiency was controlled within fold in OSP3 cells, which constitutively produce high lev-
each experiment by transfecting cells in bulk with subse- els of viral protein, to 5.7-fold in the moderately producing
quent splitting of pooled cells into stimulation protocols OSP2/4 cell line (Fig. 1). CD3 and control prl mAbs did
and verified by DNA slot blot analysis. DNA was har- not significantly alter the amount of p24 protein produced
vested using DNA Stat 60 (Tel-Test ‘‘B’’, Friendswood, TX) from these same cell lines. No increase in viral p24 pro-
and 1 mg applied to a slot blot manifold as described duction was observed in the CD2-negative cell lines.
(Andrews et al., 1995). Membranes were probed with a
randomly 32P-labeled LTR probe and quantified by phos- CD2 cross-linking increased levels of viral specific
phoimaging analysis. Variation between samples was mRNA in OSP2/4 cells
consistently less than 15%.
The increase in viral p24 protein observed could reflect
RESULTS either increased viral transcription, stabilization of viral
CD2 cross-linking induced expression of viral p24 mRNA, or enhanced assembly and release of preformed
capsid protein in HTLV-1-immortalized cell lines protein as apoptotic cells lysed. To differentiate these
mechanisms we evaluated viral RNA in OSP2/4 cells fol-Stimulation of the CD2 receptor has been reported to
induce cAMP (Hahn et al., 1991, 1993). Cyclic AMP is a lowing CD2 and CD3 receptor stimulation. After 6 hr in
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culture CD2 cross-linking resulted in an average 2.5- to
3-fold increase in all major species of viral mRNA com-
pared to unstimulated cells (Fig. 2). The relative propor-
tions of RNA species did not change following CD2 stim-
ulation, suggesting that differential splicing patterns
were not affected by receptor activation. Elevated levels
of RNA were maintained for approximately 12 hr. By 24
hr in culture RNA was degrading as cells underwent
apoptosis (data not shown). CD3 cross-linking had no
significant effect on the amount or quality of viral RNA
detected.
CD2 cross-linking increased reporter gene activity in
Jurkat cells transiently cotransfected with the viral
LTR and tax
Our Northern blot data was consistent with either sig-
nificantly enhanced mRNA stability or increased proviral
transcription following CD2 receptor engagement. To dif-
ferentiate these mechanisms we performed receptor
cross-linking studies in Jurkat transiently transfected with
a reporter gene construct under control of the HTLV-1
promoter and enhancer elements, pU3R1-CAT. Neither
CD2 nor CD3 receptor cross-linking had a significant
effect on reporter gene activity in the absence of a Tax-
expressing plasmid. However, CD2 receptor engage-
ment significantly increased reporter gene activity in Jur-
kat transiently cotransfected with pU3R1-CAT and pCMV-
tax (Fig. 3A). CAT activity in the CD2-stimulated cells
averaged 4-fold greater than that observed in the unstim-
ulated cells 12 hr after CD2 cross-linking and peaked at
11-fold greater than observed in the unstimulated cells
24 hr after CD2 stimulation. Consistent with receptor
FIG. 2. (A) CD2 stimulation of OSP2/4 cells increased viral RNA de-
modulation and strong Tax-mediated trans-activation of tected by Northern blot analysis. OSP2/4 cells were stimulated and
the HTLV-1 promoter, the difference in reporter gene ac- Northern analysis performed 6 hr after receptor stimulation. Results are
shown from one of three experiments and demonstrate an increase intivity between CD2 stimulated and unstimulated cells de-
all species of viral mRNA including unspliced genomic, singly splicedclined to an average 3-fold increase in the CD2 stimu-
envelope and doubly spliced tax messages. No significant differenceslated cells by 48 hr poststimulation. Similar results were
were observed in CD3 or control-stimulated OSP2/4 cells. As a loading
obtained in Jurkat cotransfected with a luciferase re- control membranes were stripped and reprobed with an end-labeled
porter gene construct generated in this laboratory, oligonucleotide probe specific for the human 28S ribosomal subunit. No
significant differences in loading were observed. (B) Phospho-imagingpU3R1-luc (Newbound et al., 1996), and a Tax-expressing
analysis demonstrates an approximately 4-fold increase in total viralplasmid under control of the HTLV-1 promoter, pHTLV-
RNA following CD2 cross-linking of OSP2/4 cells. Results obtained in1-tax (data not shown). Consistent with previously pub-
other experiments ranged from a 1.5- to 4.7-fold increase in viral-specific
lished reports (Copeland et al., 1995), CD3 cross-linking RNA following CD2 cross-linking of OSP2/4 cells (average 2.5-fold).
enhanced CAT activity approximately 2-fold, which was
not statistically different from controls.
of the HTLV-1 LTR, dl6-2-CAT, from which the TRE-1 and
TRE-2 sites have been deleted (Brady et al., 1987). NoCD2-receptor cross-linking enhanced reporter gene
reporter gene activity was observed in the absence ofactivity independently of Tax-responsive elements
a Tax-expressing plasmid. However, when Jurkat werewithin the HTLV-1 promoter
cotransfected with dl6-2-CAT and pCMV-tax, weak CAT
Since the CD2-mediated increase in reporter gene ac- induction was observed. Consistent with results from
tivity was dependent on coexpression of the viral trans- Brady et al. (1987), the level of reporter gene activity was
activating protein Tax, we anticipated this occurred reduced approximately 2 logs in the dl6-2-CAT-trans-
through enhanced Tax-mediated trans-activation of fected cells compared to pU3R1-CAT transfectants. Un-
cAMP consensus sequences within the Tax responsive expectedly, CD2 cross-linking increased CAT activity
elements (TREs) of the HTLV-1 promoter. To evaluate four- to ninefold over that observed in the unstimulated
dl6-2-CAT/pCMV-tax transfected cells (Fig. 3B). The levelthis we transfected Jurkat with a 5* deletional construct
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DISCUSSION
These studies demonstrate that CD2 cross-linking in-
creases HTLV-1 replication in infected lymphocytes. This
was illustrated at the protein level in CD2/ HTLV-1-in-
fected cell lines, demonstrating a 1.5- to 5.7-fold increase
in levels of p24 capsid protein 48 hr following CD2 cross-
linking. Northern blot analysis was consistent with tran-
scriptional regulation, as levels of viral-specific messen-
ger RNA were 2.5- to 4-fold greater in CD2-stimulated
OSP2/4 cells. Because the HTLV-1-infected lines consti-
tutively support high levels of viral expression, we evalu-
ated transcription directly in transiently transfected Jurkat
cells. These studies demonstrated an approximately 11-
fold enhancement in reporter gene activity following CD2
cross-linking of lymphocytes cotransfected with the
HTLV-1 LTR and pCMV-tax. These results are important
because they demonstrate that physiologic events asso-
ciated with CD2-mediated lymphocyte adhesion and acti-
vation may initiate transcription of HTLV-1.
The CD2-mediated increase in viral transcription was
associated with the induction of apoptosis in the HTLV-
1-immortalized cell lines (Guyot, 1996), which raises in-
teresting questions about the role of CD2 signaling in
the viral life cycle. However, viral infectivity, increased
transcription from the integrated provirus, neoplastic
transformation, and progression are separable issues.
We demonstrate that CD2 stimulation is one mechanism
for increasing viral transcription in both HTLV-1-immor-
FIG. 3. (A) CD2 cross-linking increases reporter gene activity in Jurkat talized cell lines and Jurkat. CD2 signaling may enhancecotransfected with pU3R1-CAT and pCMV tax. Reporter gene activity
viral infectivity in the early stages of infection or increasein Jurkat cotransfected with pU3R1-CAT and pCMV tax was monitored
expression of the viral trans-activating protein, Tax whichover a 48-hr period following receptor cross-linking. CAT activity in the
CD2-stimulated cells averaged 4-fold greater than that observed in the is postulated to be a factor in neoplastic transformation
unstimulated cells at 12 hr in culture (range 2- to 6-fold greater than (Kinoshita et al., 1989; Kira et al., 1991). Previous studies
observed in the unstimulated or prl control-stimulated cells). By 24 hr have demonstrated that loss of surface expression of thepost-CD2 stimulation, reporter gene activity averaged 11-fold greater
CD2 receptor is associated with particularly aggressivethan that observed in the unstimulated cells (range 4 to 18). Consistent
lymphoproliferative disease (Kawano, 1990), suggestingwith receptor modulation, the difference in reporter gene activity be-
tween CD2-stimulated and unstimulated cells declined to an average that subsequent down-modulation of this receptor may
3-fold increase observed in the CD2-stimulated Jurkat by 48 hr poststi- promote neoplastic progression by abrogating a host
mulation (range 3- to 4-fold). No significant difference in reporter gene mechanism for eliminating infected cells throughactivity was observed in the CD3 or prl-stimulated cells. Results are
apoptosis, again reinforcing the unique relationship be-presented from 1 of 3 representative experiments, each performed in
tween HTLV-1 and the CD2 receptor.triplicate. Statistical analysis was performed by analysis of variance.
*P  0.01. (B) Increased reporter gene activity was detected following Our results are consistent with previously published
CD2 cross-linking of Jurkat transfected with dl6-2 and pCMV-tax. No studies, demonstrating no significant effect of CD3 modu-
significant difference between mAb-stimulated and unstimulated cells lation on HTLV-1 replication (Copeland et al., 1995). Thiswas observed 12 hr after stimulation. By 24 hr, reporter gene activity
is in contrast to studies in human immunodeficiency virusin the CD2-stimulated cells averaged 6-fold greater than that observed
systems, in which either CD2 or CD3 cross-linking in-in the unstimulated cells (range 3- to 9-fold). There was an average 3-
fold increase in reporter gene activity 48 hr after transfection (range 2- creased viral replication (Bressler et al., 1991; Copeland
to 5-fold). No significant difference in reporter gene activity was ob- et al., 1995). The CD2 receptor coprecipitates with a num-
served in the CD3- or prl-stimulated cells. Results are shown from
ber of cell surface molecules which could mediate signalone of three representative experiments, each assayed in triplicate.
transduction (Le Gouvello et al., 1990; Schraven et al.,Statistical analysis was performed by analysis of variance. *P  0.05.
1990; Samstag et al., 1991; Carmo et al., 1993; Meuer et
al., 1995). However, CD2 signaling is postulated to occur
primarily through the CD3 e and z chains (Howard et al.,of CAT activity was low but within the linear range of the
1992; Moingeon et al., 1992; Sehajpal et al., 1993). Whileassay employed and represents a level of CD2 enhance-
coexpression of CD3 may be required for CD2 signalingment comparable to that observed with the full length
promoter construct. in these systems, cross-linking of the CD3 e chain had
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Gazzolo, L., and Duc Dudon, M. (1987). Direct activation of resting Tminimal effects on HTLV-1 transcription, suggesting di-
cells by HTLV-1. Nature (London) 326, 714–717.vergence of these signaling pathways as they affect the
Gessain, A., Barin, F., Vernant, J., Gout, O., Maurs, L., Calender, A., andHTLV-1 promoter. De-The´, G. (1985). Antibodies to human T-lymphotropic virus type 1
The CD2-mediated increase in transcription was de- in patients with tropical spastic paraparesis. Lancet II, 407–410.
pendent upon coexpression of the viral trans-activating Green, P., and Chen, I. (1990). Regulation of human T-cell leukemia
virus expression. FASEB J. 4, 169–175.protein Tax and is postulated to occur primarily through
Greene, W. C., Leonard, W. J., Wano, Y., Svetlik, P. B., Peffer, N. J., So-enhanced tax-mediated trans-activation of the LTR. Inter-
droski, J. B., Rosen, J. B., Goh, W. C., and Haseltine, W. A. (1986).estingly, however, CD2 cross-linking also increased re-
Transactivating gene of HTLV-1I induces IL-2 receptor and IL-2 cellu-
porter gene activity in Jurkat transfected with a plasmid lar gene expression. Science 232, 887–880.
construct containing only the core promoter and down- Guyot, D. J., Trask, O. J., Andrews, J. M., Newbound, G. C., and Lairmore,
M. D. (1996). Stimulation of the CD2 receptor pathway inducesstream regulatory elements. Levels of transcription in this
apoptosis in human T lymphotropic virus type 1-infected cell line. J.system were low, and the significance of this finding is
AIDS Hum. Retroviruses 11, 317–325.uncertain. CD2 cross-linking may enhance basal tran-
Hahn, W. C., Rosenstein, Y., Burakoff, S. J., and Bierer, B. E. (1991).scription through Sp-1 elements (Barnhart, 1997), TFIID Interaction of CD2 with its ligand LFA-3 induces adenosine 3*–5*
or TFIIA binding at the TATA box, or DRE-1/YB-1 interac- cyclic monophosphate production in T lymphocytes. J. Immunol. 147,
tions (Kashanchi et al., 1993; Duvall et al., 1995; Caron et 14–21.
Hahn, W. C., and Bierer, B. E. (1993). Separable portions of the CD2al., 1993). Alternatively, CD2 stimulation could eliminate a
cytoplasmic domain involved in signaling and ligand avidity regula-transcriptional repressor, such as binding of a CREB fac-
tion. J. Exp. Med. 178, 1831–1836.tor to the R region, which has been implicated in the
Hinuma, Y., Nagata, K., Hanoaka, M., Nakai, M., Matsumoto, T., Kino-
suppression of basal transcription (Xu et al., 1994). Fur- shita, K., Shirakawa, S., and Miyoshi, I. (1981). Adult T-cell leukemia:
ther study will be required to localize the CD2-responsive Antigen in an ATL cell line and detection of antibodies to the antigen
in human sera. Proc. Natl. Acad. Sci. USA 78, 6476–6480.elements within the HTLV-1 promoter and define the sig-
Howard, F. D., Moingeon, P., Mobius, U., McKonkey, D. J., Yandava, B.,naling pathways through which this occurs.
Gennert, T. E., and Reinherz, E. L. (1992). The CD3 zeta cytoplasmic
domain mediates CD2-induced T cell activation. J. Exp. Med. 176,
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